Targeting HIF-1α promotes ferroptosis and boosts antitumor immunity in MSS colorectal cancer
Redox Biology · 2026-06 · 93 · 104151
DOI: 10.1016/j.redox.2026.104151 ↗Kurz gefasst
Fachartikel in der Zeitschrift Redox Biology, 2026-06. Verfasst von Zhiying Yang und 10 weiteren Autor:innen. Beteiligte Einrichtung: Guangdong Institute of Gastroenterology, Guangzhou, China; Department of General Surgery, The Sixth Affiliated Hospital, Sun Yat-sen University, Guan…. Hauptthemen laut MEDLINE: Hypoxia-Inducible Factor 1, alpha Subunit, Ferroptosis, Colorectal Neoplasms. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 39 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Natural Science Foundation of Guangdong Province, Sun Yat-sen University, Basic and Applied Basic Research Foundation of Guangdong Province.
Abstract (Originalsprache)
The lack of effective therapeutic options available for microsatellite stable (MSS) colorectal cancer (CRC) remains a significant clinical challenge. Interestingly, chemotherapy-resistant cancer cells can be induced to undergo ferroptosis, prompting our investigation into RSL3, a potent ferroptosis inducer, in MSS CRC cells. Our findings revealed that while RSL3 suppressed the growth of MSS CRC cells, a subset displayed resistance. Single-cell sequencing uncovered an aberrant activation of hypoxia pathways in RSL3-resistant MSS CRC cells. Inhibiting HIF-1α, the key transcription factor driving hypoxia signaling, restored RSL3 sensitivity in these resistant cells; moreover, this sensitivity was attenuated upon HIF-1α overexpression. Chromatin immunoprecipitation assays further demonstrated that in RSL3-resistant cells, HIF-1α was enriched at the promoter of P4HA1, a gene implicated in ferroptosis resistance, thereby enhancing its expression. Additionally, in vivo experiments using syngeneic transplantation of CT26 cells in mice revealed that combining RSL3 with an HIF-1α inhibitor markedly enhanced tumor suppression and metastasis prevention, concomitant with increased intratumoral infiltration of CD8+ T cells and CD86+ macrophages. Notably, the combination enhanced the antitumor response of anti-PD1, a treatment otherwise ineffective on this tumor. These findings suggest that targeting HIF-1α represents a promising therapeutic strategy when used in conjunction with a ferroptosis inducer for the treatment of MSS CRC.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Guangdong Institute of Gastroenterology, Guangzhou, China; Department of General Surgery, The Sixth Affiliated Hospital, Sun Yat-sen University, Guangzhou, China; Guangdong Provincial Key Laboratory of Colorectal and Pe…
- Department of Medical Oncology, The Seventh Affiliated Hospital, Sun Yat-sen University, Shenzhen, China.
- People's Hospital of Pingshan, Shenzhen, China; Pingshan Hospital, Southern Medical University, Shenzhen, China.
- School of Life Sciences, Sun Yat-sen University, Guangzhou, China.
- Department of Dermatology, Heyou Hospital, Shunde District, Foshan, China.
- Department of Medical Oncology, The Seventh Affiliated Hospital, Sun Yat-sen University, Shenzhen, China. Electronic address: wangb76@mail.sysu.edu.cn.
Förderung
- Natural Science Foundation of Guangdong Province
- Sun Yat-sen University
- Basic and Applied Basic Research Foundation of Guangdong Province
- Sanming Project of Medicine in Shenzhen
- National Natural Science Foundation of China
Zitieren
APA
Yang, Z., Ma, R., Wu, W., Shi, Y., Chen, Y., Luo, X., Li, K., Wu, L., Wang, B., Zhang, B., & Yuan, P. (2026). Targeting HIF-1α promotes ferroptosis and boosts antitumor immunity in MSS colorectal cancer. Redox Biology, 93, 104151. https://doi.org/10.1016/j.redox.2026.104151
Vancouver
Yang Z, Ma R, Wu W, Shi Y, Chen Y, Luo X, et al. Targeting HIF-1α promotes ferroptosis and boosts antitumor immunity in MSS colorectal cancer. Redox Biology. 2026;93:104151. doi:10.1016/j.redox.2026.104151
BibTeX
@article{Yang2026,
author = {Yang, Zhiying and Ma, Rui and Wu, Weili and Shi, Ying and Chen, You and Luo, Xiaotong and Li, Kai and Wu, Liangcai and Wang, Bo and Zhang, Boyu and Yuan, Ping},
title = {Targeting HIF-1α promotes ferroptosis and boosts antitumor immunity in MSS colorectal cancer},
journal = {Redox Biology},
year = {2026},
volume = {93},
pages = {104151},
doi = {10.1016/j.redox.2026.104151}
}
EUVIMED